Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04617184 · ClinicalTrials.gov registry record
Registry and Biorepository for IBD in Central Texas
A clinical trial of Ulcerative Colitis and Crohn Disease, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT04617184: Recruiting study of Ulcerative Colitis and Crohn Disease, sponsored by University of Texas at Austin.
NCT04617184 is a study of Ulcerative Colitis and Crohn Disease that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 1,000 participants, below the 2,049-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04617184, a study of Ulcerative Colitis and Crohn Disease, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or endoscopy). Participants may choose to provide any or all of the aforementioned information and/or samples.
Primary Outcome
Number of patients with Crohns, ulcerative colitis, and IBD undetermined
Conditions Studied
Interventions
- OTHER NO INTERVENTION
Study Locations (1)
Texas
- Dell Medical School, UT Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2030-12-31 |
What NCT04617184 shows while recruiting
NCT04617184 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 2,049-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (51% lower).
The record links to 3 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 1 intervention - of which NO INTERVENTION is the first listed.
NCT04617184 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04617184 about?
NCT04617184 is a clinical study titled "Registry and Biorepository for IBD in Central Texas". This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples,...
What is the current status of trial NCT04617184?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2021-06-01. Estimated completion is 2030-12-31.
What conditions does trial NCT04617184 study?
This clinical trial studies the following conditions: Ulcerative Colitis, Crohn Disease, Inflammatory Bowel Diseases.
What interventions are being tested in trial NCT04617184?
The interventions under investigation include: NO INTERVENTION (OTHER).
Who is sponsoring clinical trial NCT04617184?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04617184 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04617184's enrollment target sits among peer trials
1,000 12th of 122 higher than 110 of 122 other Ulcerative Colitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ulcerative Colitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RECRUITING · Phase 2
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
-
Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI